MicroVascular Tissues
San Diego-based MicroVascular Tissues develops and implants biological vascular tissues since 2014.
Founded
2014San Diego-based MicroVascular Tissues develops and implants biological vascular tissues since 2014.
MicroVascular Tissues, founded in 2014 as a management-led spin-out from Tornier Inc., is based in San Diego, California. The company focuses on developing biological vascular tissues for implantation, aiming to address microvascular deficiencies. Their core mission is to enhance healing potential by increasing blood flow and providing the foundation for tissue repair through their innovative mVASC microvascular tissue solutions. These products are designed to repair, reconstruct, and replace damaged microvascular tissues, thereby improving patient outcomes in various medical conditions.
Notable affiliated individuals and investors include key figures from the biomedical and venture capital sectors, although specific names are not disclosed. Since its inception, MicroVascular Tissues has made significant strides in the field of regenerative medicine, contributing to advancements in tissue engineering and vascular health. Their impact is reflected in the improved healing processes and quality of life for patients with microvascular deficiencies.
Companies similar to MicroVascular Tissues include Micro Medical Solutions, Vascudyne, Histogen and Vascular Imaging.
MicroVascular Tissues was founded in 2014.
MicroVascular Tissues' headquarters is located in San Diego, CA, US.
MicroVascular Tissues' most recent funding round was for $4.1M (USD) in March 2023.
As of Mar 10, 2023, MicroVascular Tissues has disclosed funding of $9.6M (USD). Undisclosed round amounts are excluded.
MicroVascular Tissues has 30 employees as of Feb 4, 2024.
